This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) has taken a more defensive pricing stance in China as competitive pressures around obesity treatments continue to build. Local media ...

Over 15% of Tamil Nadu electors have been deleted from the voter lists as part of the ongoing Special Intensive Revision (SIR) of the electoral rolls. In Chennai alone, more than 35% of voters’ names ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

TIOBE Programming Index News – November 2025: C# Closes In on Java Your email has been sent The November 2025 TIOBE Index brings another twist below Python’s familiar lead. C solidifies its position ...

If the most creativity an animated film primarily set in children’s dreams can conjure up is a pizza-themed version of “Don’t Cha” (“Don’t cha wish your pizza was a freak like me?” an animatronic ...

Democrats are up 8 points over Republicans on a generic congressional ballot, according to new polling. In the NBC News survey released Sunday, 50 percent of respondents said they wanted “a Congress ...

Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a new plan on Wednesday that he said will drastically reduce drug prices in the U.S. He said the U.S. Food and Drug Administration is ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

Forbes contributors publish independent expert analyses and insights. Amir is Founder of AI unicorn Avathon & Boeing/SC JV, SkyGrid. Recently, a friend asked me a question that's been floating around ...

What if you could strip away the layers of abstraction that operating systems impose and interact directly with your computer’s hardware? Imagine crafting a program where every instruction is executed ...

Bausch Health (NYSE:BHC) and Teva (NYSE:TEVA) are facing a lawsuit accusing them of conspiring to delay the release of a cheaper generic version of Bausch’s diarrhea drug, Xifaxan, keeping prices ...